Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lung Deposition of Inhaled S-770108 in Healthy Adults
NCT04631354Phase 1Completed
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Nov 2020
- Primary completion
- Dec 2020
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial in idiopathic pulmonary fibrosis (IPF) (2 arms), sponsored by Shionogi & Co., Ltd. Primary endpoint: Total lung deposition of 99mTc radio-labelled S-770108 at Day 1. Started Nov 2020; status: completed.
02
Conditions
idiopathic pulmonary fibrosis (IPF)
Beyond the preview
Go deeper on NCT04631354.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04631354.